New CDK4/6i Data Move Metastatic Breast Cancer Field Forward

At ASCO 2017, the MONARCH-3, PALOMA-1, AND TREnd trials shed light on the efficacy of new CDK4/6 inhibitors for metastatic breast cancer.

Source: Medscape Oncology - June 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts